Purdue Settles Oklahoma Opioid Suit for $270 Million

Drug Industry Daily
A A
Purdue and its owners on Tuesday agreed to pay $270 million to settle a lawsuit bought by Oklahoma officials, avoiding what would have been the first jury trial in a nationwide opioid crisis that may end up costing drugmakers billions.

To View This Article:

Login

Subscribe To Drug Industry Daily